<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8299">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01990404</url>
  </required_header>
  <id_info>
    <org_study_id>12 066 08</org_study_id>
    <secondary_id>2012-004129-25</secondary_id>
    <nct_id>NCT01990404</nct_id>
  </id_info>
  <brief_title>Efficacy of Premixed Nitrous Oxide and Oxygen in Elderly Patient With Out-of-hospital Severe Acute Pain</brief_title>
  <acronym>MEOPA-PA</acronym>
  <official_title>Efficacy of Premixed Nitrous Oxide and Oxygen in Elderly Patient With Out-of-hospital Severe Acute Pain: a Randomized Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain in the elderly is poorly evaluated and clearly under treated. Premixed nitrous oxide
      and oxygen is used in the emergency medical care of the trauma, burns, during transport of
      patient with pain. None randomized study has validated the use of premixed nitrous oxide and
      oxygen in the emergency department in the elderly. The aim of the study is to demonstrate
      the efficacy of premixed nitrous oxide and oxygen compared to medical air in elderly patient
      with out-of-hospital severe acute pain
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary endpoint is the percentage of patients with pain relief (with a numerical rating
      scale of 3/10 or lower) 15 minutes after randomisation. Secondary endpoints are treatment
      safety and adverse events, time to analgesia and duration of analgesia. This study will
      expect 108 patients assigned in two parallel groups, defined by a randomization scheme. Four
      sites will participate to the research. Eligible patients with a numeric rating scale (NRS)
      score higher than 6/10 are randomly allocated to receive either MEOPA, or medical air.
      Neither the investigator nor the nurse knows the treatment. Pain score will be measured at
      baseline and every 5 minutes until pain relief will be obtained. The safety evaluation will
      include non invasive monitoring of blood pressure, heart rate, and oxygen saturation by
      pulse oximetry (SpO2) and adverse events collection.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The primary endpoint is the percentage of patients with pain relief (with a numerical rating scale of 3/10 or lower)</measure>
    <time_frame>15 minutes after randomisation</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse events</measure>
    <time_frame>From the randomization until 48 hours after randomization</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to analgesia</measure>
    <time_frame>From randomization until 48 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of analgesia.</measure>
    <time_frame>From randomization until 48 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Severe Acute Pain</condition>
  <arm_group>
    <arm_group_label>Premixed 50% nitrous oxide and oxygen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Medical air</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Premixed nitrous oxide and oxygen MEOPA</intervention_name>
    <description>Premixed 50% nitrous oxide and oxygen is a gas in cylinder of 5 litres delivered by a face mask. The gases of the study are contained in anonymous bottles of the same capacity. Bottles will only be differentiated by a letter: A or B.</description>
    <arm_group_label>Premixed 50% nitrous oxide and oxygen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Medical Air</intervention_name>
    <description>Medical air is a gas in cylinder of 5 litres delivered by a face mask. The gases of the study are contained in anonymous bottles of the same capacity. Bottles will only be differentiated by a letter: A or B</description>
    <arm_group_label>Medical air</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 65 years old and over

          -  Severe acute pain (NRS score greater than 6)

        Exclusion Criteria:

          -  Contraindication of premixed 50% nitrous oxide and oxygen
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent Bounes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vincent BOUNES, MD</last_name>
    <phone>05 67 69 16 76</phone>
    <phone_ext>33</phone_ext>
    <email>bounes.v@chu-toulouse.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>SAMU Bobigny</name>
      <address>
        <city>Bobigny</city>
        <zip>93000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frédéric Adnet, MD</last_name>
    </contact>
    <investigator>
      <last_name>Frédéric Adnet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SAMU St-Denis de la Réunion</name>
      <address>
        <city>St-Denis de la Réunion</city>
        <zip>97405</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Combes, MD</last_name>
    </contact>
    <investigator>
      <last_name>Xavier Combes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SAMU Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Bounes, MD</last_name>
    </contact>
    <investigator>
      <last_name>Vincent Bounes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Jones JS, Johnson K, McNinch M. Age as a risk factor for inadequate emergency department analgesia. Am J Emerg Med. 1996 Mar;14(2):157-60.</citation>
    <PMID>8924137</PMID>
  </reference>
  <reference>
    <citation>Rupp T, Delaney KA. Inadequate analgesia in emergency medicine. Ann Emerg Med. 2004 Apr;43(4):494-503. Review.</citation>
    <PMID>15039693</PMID>
  </reference>
  <reference>
    <citation>Doan BD. [Aging of population and medical workforce: a prospective view of health care provision in France in the year 2025]. Cah Sociol Demogr Med. 2004 Apr-Jun;44(2):243-66. French.</citation>
    <PMID>15241964</PMID>
  </reference>
  <reference>
    <citation>Strange GR, Chen EH. Use of emergency departments by elder patients: a five-year follow-up study. Acad Emerg Med. 1998 Dec;5(12):1157-62.</citation>
    <PMID>9864128</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 14, 2013</lastchanged_date>
  <firstreceived_date>September 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Premixed nitrous oxide and oxygen</keyword>
  <keyword>Severe acute pain</keyword>
  <keyword>Prehospital setting</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nitrous Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
